Skip to main content
Log in

Magnesium retards the progress of the arterial calcifications in hemodialysis patients: a pilot study

  • Nephrology - Original Paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Background

The aim of the study was to evaluate the impact of magnesium (Mg) on the evolution of arterial calcifications in hemodialysis patients.

Patients and methods

Seventy-two stable hemodialysis patients were randomly allocated to two groups: 36 administered a regimen containing magnesium carbonate plus calcium acetate as a phosphate binder (Mg group), while the rest 36 received calcium acetate alone (Ca group). The presence and the progression of arterial calcifications were evaluated in plain X-rays using a simple vascular calcification score. The duration of the follow-up period was 12 months.

Results

Thirty-two patients of the Mg group and 27 of the Ca group completed the study. The mean time average values of the biochemical laboratories did not differ between the two groups, except serum Mg: 2.83 + 0.38 in the Mg group versus 2.52 + 0.27 mg/dl in the Ca group, p = 0.001. In 9/32 (28.12 %) patients of the Mg group and in 12/27 (44.44 %) patients of the Ca group, the arterial calcifications were worsened, p = 0.276. Moreover, in 4/32 (15.6 %) patients of the Mg group and in 0/27 (0 %) patients of the Ca group, they were improved, p = 0.040. The multivariate logistic regression analysis revealed that serum magnesium was an independent predictor for no progression of the arterial calcifications, p = 0.047.

Conclusions

Magnesium probably retards the arterial calcifications in hemodialysis patients. Further clinical studies are needed to clarify whether magnesium provides cardiovascular protection to this group of patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Foley RN, Parfrey PS (1998) Cardiovascular disease and mortality in ESRD. J Nephrol 11:239–245

    PubMed  CAS  Google Scholar 

  2. Speer MY, Giachelli CM (2004) Regulation of cardiovascular calcification. Cardiovasc Pathol 13:63–70

    Article  PubMed  CAS  Google Scholar 

  3. Rayssiguier Y (1986) Magnesium, lipids and vascular diseases. Experimental evidence in animal models. Magnesium 5(3–4):182–190

    PubMed  CAS  Google Scholar 

  4. Cohen H, Sherer Y, Shaish A, Shoenfeld Y, Levkovitz H, Bitzur R et al (2002) Atherogenesis inhibition induced by magnesium-chloride fortification of drinking water. Biol Trace Elem Res 90(1–3):251–259

    Article  PubMed  CAS  Google Scholar 

  5. Schwille PO, Schmiedl A, Schwille R, Brunner P, Kissler H, Cesnjevar R et al (2003) Media calcification, low erythrocyte magnesium, altered plasma magnesium, and calcium homeostasis following grafting of the thoracic aorta to the infrarenal aorta in the rat differential preventive effects of long-term oral magnesium supplementation alone and in combination with alkali. Biomed Pharmacother 57(2):88–97

    Article  PubMed  CAS  Google Scholar 

  6. Kircelli F, Peter ME, Ok ES, Celenk FG, Yilmaz M, Steppan S et al (2012) Magnesium reduces calcification in bovine vascular smooth muscle cells in a dose-dependent manner. Nephrol Dial Transplant 27:514–521

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  7. Salem S, Bruck H, Bahlmann FH, Peter M, Passlick-Deetjen J, Kretschmer A et al (2012) Relationship between magnesium and clinical biomarkers on inhibition of vascular calcification. Am J Nephrol 35(1):31–39

    Article  PubMed  CAS  Google Scholar 

  8. Louvet L, Büchel J, Steppan S, Passlick-Deetjen J, Massy ZA (2013) Magnesium prevents phosphate-induced calcification in human aortic vascular smooth muscle cells. Nephrol Dial Transplant 28:869–878

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  9. Meema HE, Oreopoulos DG, Rapoport A (1987) Serum magnesium level and arterial calcification in end-stage renal disease. Kidney Int 32:388–394

    Article  PubMed  CAS  Google Scholar 

  10. Tzanakis I, Pras A, Kounali D, Mamali V, Kartsonakis V, Mayopoulou-Symvoulidou D et al (1997) Mitral annular calcifications in haemodialysis patients: a possible protective role of magnesium. Nephrol Dial Transplant 12(9):2036–2037

    Article  PubMed  CAS  Google Scholar 

  11. Tzanakis I, Virvidakis K, Tsomi A, Mantakas E, Girousis N, Karefyllakis N et al (2004) Intra- and extracellular magnesium levels and atheromatosis in haemodialysis patients. Magnes Res 17(2):102–108

    PubMed  CAS  Google Scholar 

  12. Ishimura E, Okuno S, Kitatani K, Tsuchida T, Yamakawa T, Shioi A, Inaba M, Nishizawa Y (2007) Significant association between the presence of peripheral vascular calcification and lower serum magnesium in hemodialysis patients. Clin Nephrol 68(4):222–227

    Article  PubMed  CAS  Google Scholar 

  13. Spiegel DM, Farmer B (2009) Long-term effects of magnesium carbonate on coronary artery calcification and bone mineral density in hemodialysis patients: a pilot study. Hemodial Int 13:453–459

    Article  PubMed  Google Scholar 

  14. Ishimura E, Okuno S, Yamakawa T, Inaba M, Nishizawa Y (2007) Serum magnesium concentration is a significant predictor of mortality in maintenance hemodialysis patients. Magnes Res 20(4):237–244

    PubMed  CAS  Google Scholar 

  15. Tzanakis I, Tsomi A, Mantakas E, Papadaki A, Kallivretakis N (2006) The higher intracellular magnesium, the better long-term survival on hemodialysis. Presented in ASN Congress (Renal Week) November 14–19 2006, San Diego, USA

  16. Lacson EK, Wang W, Lazarus M, Hakim R (2009) Magnesium and mortality risk in hemodialysis patients. Presented in ASN Congress (Renal Week), October 27–November 1, 2009, San Diego, USA

  17. Kanbay M, Yilmaz MI, Apetrii M, Saglam M, Yaman H, Unal HU et al (2012) Relationship between serum magnesium levels and cardiovascular events in chronic kidney disease patients. Am J Nephrol 36(3):228–237

    Article  PubMed  CAS  Google Scholar 

  18. Adragao T, Pires A, Lucas C, Birne R, Magalhaes L, Gonçalves M et al (2004) A simple vascular calcification score predicts cardiovascular risk in haemodialysis patients. Nephrol Dial Transplant 19:1480–1488

    Article  PubMed  Google Scholar 

  19. Adragão T, Pires A, Birne R, Curto JD, Lucas C, Gonçalves MA et al (2009) A plain X-ray vascular calcification score is associated with arterial stiffness and mortality in dialysis patients. Nephrol Dial Transplant 24:997–1002

    Article  PubMed  Google Scholar 

  20. Adragao T, Pires A, Branco P, Curto JD, Lucas C, Gonçalves M et al (2012) Ankle–brachial index, vascular calcifications and mortality in dialysis patients. Nephrol Dial Transplant 27(1):318–325

    Article  PubMed  Google Scholar 

  21. Wei M, Esbaei K, Bargman JM, Oreopoulos DG (2006) Inverse correlation between serum magnesium and parathyroid hormone in peritoneal dialysis patients: a contributing factor to a dynamic bone disease? Int Urol Nephrol 38:317–322

    Article  PubMed  CAS  Google Scholar 

  22. Contiguglia SR, Alfrey AC, Miller NL, Runnells DE, Le Geros RZ (1973) Nature of soft tissue calcification in uremia. Kidney Int 4:229–235

    Article  PubMed  CAS  Google Scholar 

  23. Schoppet M, Shroff RC, Hofbauer LC, Shanahan CM (2008) Exploring the biology of vascular calcification in chronic kidney disease: what’s circulating? Kidney Int 73:384–390

    Article  PubMed  CAS  Google Scholar 

  24. Bennett RM, Lehr JR, McCarty DJ (1975) Factors affecting the solubility of calcium pyrophosphate dehydrate crystals. J Clin Invest 56:1571–1579

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  25. Massy Ziad A, Drueke Tilman B (2012) Magnesium and outcomes in patients with chronic kidney disease: focus on vascular calcification, atherosclerosis and survival. Clin Kidney J 5(Suppl 1):i52–i61

    Article  CAS  Google Scholar 

  26. Giachelli CM, Jono S, Shioi A, Nishizawa Y, Mori K, Morii H (2001) Vascular calcification and inorganic phosphate. Am J Kidney Dis 38:34–37

    Article  Google Scholar 

  27. Shanahan CM (2005) Mechanisms of vascular calcification in renal disease. Clin Nephrol 63:146–157

    Article  PubMed  CAS  Google Scholar 

  28. Moe SM, Drueke T, Lameire N, Eknoyan G (2007) Chronic kidney disease mineral-bone disorder: a new paradigm. Adv Chronic Kidney Dis 14:3–12

    Article  PubMed  Google Scholar 

  29. De Schutter TM, Behets GJ, Geryl H, Peter ME, Steppan S, Gundlach K (2013) Effect of a magnesium-based phosphate binder on medial calcification in a rat model of uremia. Kidney Int 83(6):1109–1117

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Conflict of interest

All the authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ioannis P. Tzanakis.

Additional information

Dimitrios G. Oreopoulos: Deceased.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tzanakis, I.P., Stamataki, E.E., Papadaki, A.N. et al. Magnesium retards the progress of the arterial calcifications in hemodialysis patients: a pilot study. Int Urol Nephrol 46, 2199–2205 (2014). https://doi.org/10.1007/s11255-014-0751-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-014-0751-9

Keywords

Navigation